{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:12Z","timestamp":1791919992162,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001724","name":"International Foundation for Science","doi-asserted-by":"publisher","award":["F\/4081-1"],"award-info":[{"award-number":["F\/4081-1"]}],"id":[{"id":"10.13039\/501100001724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001724","name":"International Foundation for Science","doi-asserted-by":"publisher","award":["F\/4081-2"],"award-info":[{"award-number":["F\/4081-2"]}],"id":[{"id":"10.13039\/501100001724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001724","name":"International Foundation for Science","doi-asserted-by":"publisher","award":["F\/5198-1"],"award-info":[{"award-number":["F\/5198-1"]}],"id":[{"id":"10.13039\/501100001724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["031\/2013 PR\u00d3-DEFESA 3"],"award-info":[{"award-number":["031\/2013 PR\u00d3-DEFESA 3"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/24587-9"],"award-info":[{"award-number":["2016\/24587-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bbagen.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:23:27Z","timestamp":1537619007000},"page":"2911-2923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures"],"prefix":"10.1016","volume":"1862","author":[{"given":"Jorge E.","family":"Hern\u00e1ndez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Salas-Sarduy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa F.","family":"Hern\u00e1ndez Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego E.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Pab\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor B.P.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.","family":"Pascutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Valiente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2018.09.015_bb0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1389450117666161221122432","article-title":"Targeting cysteine proteases from Plasmodium falciparum: a general overview, rational drug design and computational approaches for drug discovery","volume":"19","author":"Bekono","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0010","author":"World Malaria Report"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0015","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/092986711795328328","article-title":"Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria","volume":"18","author":"Teixeira","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijantimicag.2017.04.006","article-title":"Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges","volume":"50","author":"Roy","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.20163","article-title":"Falcipain-2 inhibitors","volume":"30","author":"Ettari","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0030","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/prot.25322","article-title":"Predicting binding modes of reversible peptide-based inhibitors of falcipain-2 consistent with structure-activity relationships","volume":"85","author":"Hernandez Gonzalez","year":"2017","journal-title":"Proteins"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0035","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.bpj.2010.02.034","article-title":"Improved ligand-protein binding affinity predictions using multiple binding modes","volume":"98","author":"Stjernschantz","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ci700470c","article-title":"Investigation of MM-PBSA rescoring of docking poses","volume":"48","author":"Thompson","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/ci100354x","article-title":"Postprocessing of docked protein-ligand complexes using implicit solvation models","volume":"51","author":"Lindstrom","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0050","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcc.21666","article-title":"Assessing the performance of the molecular mechanics\/Poisson Boltzmann surface area and molecular mechanics\/generalized born surface area methods. II. The accuracy of ranking poses generated from docking","volume":"32","author":"Hou","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0060","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/acs.jctc.6b00201","article-title":"Prediction of protein-ligand binding poses via a combination of induced fit docking and metadynamics simulations","volume":"12","author":"Clark","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0065","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/protein\/gzp040","article-title":"Alignment of multiple protein structures based on sequence and structure features","volume":"22","author":"Madhusudhan","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1126\/science.7280687","article-title":"Similar amino acid sequences: chance or common ancestry?","volume":"214","author":"Doolittle","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0085","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0090","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pep.2012.03.008","article-title":"High-level expression of Falcipain-2 in Escherichia coli by codon optimization and auto-induction","volume":"83","author":"Sarduy","year":"2012","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pro.5560060421","article-title":"Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex","volume":"6","author":"Linnevers","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/14756366.2014.920839","article-title":"Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum","volume":"30","author":"Bertoldo","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0042-104283","article-title":"Antiplasmodial and cytotoxic activity of raw plant extracts as reported by knowledgeable indigenous people of the Amazon Region (Vaupes Medio in Colombia)","volume":"82","author":"Pabon","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0130","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1073\/pnas.83.22.8713","article-title":"A repetitive antigen of Plasmodium falciparum that is homologous to heat shock protein 70 of Drosophila melanogaster","volume":"83","author":"Bianco","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2017.10.010","article-title":"Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry","volume":"149","author":"Pascual","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0140","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J.A. Montgomery Jr., J.E. Peralta, F. Ogliaro, M.J. Bearpark, J. Heyd, E.N. Brothers, K.N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A.P. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N.J. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannenberg, S. Dapprich, A.D. Daniels, \u00d6. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski, D.J. Fox, Gaussian 09, Gaussian, Inc., Wallingford, CT, USA, 2009."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0145","series-title":"AMBER14","author":"Case","year":"2014"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0150","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0155","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0160","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/978-1-61779-465-0_30","article-title":"Accelerated molecular dynamics in computational drug design","volume":"819","author":"Wereszczynski","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0170","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0175","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/ct700119m","article-title":"Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms","volume":"3","author":"Shao","year":"2007","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0190","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/ct8002354","article-title":"Standard free energy of binding from a one-dimensional potential of mean Force","volume":"5","author":"Doudou","year":"2009","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010079","article-title":"Computer-aided drug design using sesquiterpene lactones as sources of new structures with potential activity against infectious neglected diseases","volume":"22","author":"Herrera Acevedo","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0200","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.pt.2016.08.002","article-title":"Discovery of novel antischistosomal agents by molecular modeling approaches","volume":"32","author":"Mafud","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2013.01.002","article-title":"Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity","volume":"187","author":"Cotrin","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0215","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/bj20030438","article-title":"S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates","volume":"373","author":"Alves","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ab.2004.09.012","article-title":"Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B","volume":"335","author":"Cotrin","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.abb.2004.07.006","article-title":"Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L","volume":"430","author":"Puzer","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0230","doi-asserted-by":"crossref","first-page":"30238","DOI":"10.1016\/S0021-9258(18)43803-3","article-title":"Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity","volume":"269","author":"Bromme","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0235","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0240","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M211968200","article-title":"Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data","volume":"278","author":"Kuo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0245","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible inhibitors of serine, cysteine, and threonine proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02174044","article-title":"Recent insights into cysteine protease specificity: lessons for drug design","volume":"6","author":"Storer","year":"1996","journal-title":"Perpect. Drug Discov. Des."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0255","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum","volume":"275","author":"Shenai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0260","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/ci200029y","article-title":"Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library","volume":"51","author":"Shah","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3410\/B3-19","article-title":"Conformational selection or induced fit? 50 years of debate resolved","volume":"3","author":"Changeux","year":"2011","journal-title":"F1000 Biol. Rep."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0270","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1110\/ps.062666607","article-title":"The S2 subsites of cathepsins K and L and their contribution to collagen degradation","volume":"16","author":"Lecaille","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003759","article-title":"Insights into the interactions of Fasciola hepatica cathepsin L3 with a substrate and potential novel inhibitors through in silico approaches","volume":"9","author":"Hernandez Alvarez","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000676","article-title":"Computational identification of uncharacterized cruzain binding sites","volume":"4","author":"Durrant","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/abbi.2000.1905","article-title":"Molecular modeling and substrate specificity of discrete cruzipain-like and cathepsin L-like cysteine proteinases of the human blood fluke Schistosoma mansoni","volume":"380","author":"Brady","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0290","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/jp404160y","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 3. The impact of force fields and ligand charge models","volume":"117","author":"Xu","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0295","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0300","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0305","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","article-title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum","volume":"95","author":"Waller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0310","first-page":"666","article-title":"Quinoid compounds cause inhibition of falcipain 2, and arrest Plasmodium falciparum growth in vitro","volume":"33","author":"Duran-Lengua","year":"2014","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0315","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/ci200029y","article-title":"Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library","volume":"51","author":"Shah","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0320","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17460441.2012.668520","article-title":"Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease","volume":"7","author":"Nicoll-Griffith","year":"2012","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bbagen.2018.09.015_bb0325","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/ci2005516","article-title":"Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis","volume":"52","author":"Shah","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbagen.2018.09.015_bb0330","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1021\/bi025638x","article-title":"Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity","volume":"41","author":"Lecaille","year":"2002","journal-title":"Biochemistry"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518303039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518303039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:03:01Z","timestamp":1759636981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416518303039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0304416518303039"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.09.015","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}